Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis
A feature of thymomas is their frequent association with myasthenia gravis (MG), an autoimmune disease characterized by the production of autoantibodies directed to different targets at the neuromuscular junction. Indeed, almost 30–40% of thymomas are found in patients with a type of MG termed thymo...
Main Authors: | Fabio Coppedè, Roberta Ricciardi, Angela Lopomo, Andrea Stoccoro, Anna De Rosa, Melania Guida, Loredana Petrucci, Michelangelo Maestri, Marco Lucchi, Lucia Migliore |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2020.567676/full |
Similar Items
-
Clinical Implications of Promoter Hypermethylation in RASSF1A and MGMT in Retinoblastoma
by: Kwong Wai Choy, et al.
Published: (2005-03-01) -
Expression of MGMT, hMLH1 and XRCC1 in Gastric Cancer Tissue and Their Clinical Significance
by: Xiao-feng LI, et al.
Published: (2015-03-01) -
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma
by: Yusuke Funakoshi, et al.
Published: (2021-05-01) -
APC, BRAF and KRAS mutations, and MLH1, MGMT and CDKN2A expression analysis in Nepalese colorectal cancer patients. : -
by: Nourizadeh, Alireza
Published: (2017) -
Aberrantly Methylated MGMT, hMLH1 and hMSH2 in Tumor and Serum DNA of Gliomas Patients
by: Chanqing ZHENG, et al.
Published: (2009-02-01)